Close

EBNA3

All products and services are For Research Use Only and CANNOT be used in the treatment or diagnosis of disease.

Plays an essential role for activation and immortalization of human B-cells. Represses transcription of viral promoters TP1 and Cp through interaction with host RBPJ, and inhibits EBNA2-mediated activation of these promoters. Since Cp is the promoter for all EBNA mRNAs, EBNA3A probably contributes to a negative autoregulatory control loop.

Associated Disease
  • EBV infection
  • TCR Vector Products

  • TCR Cell Products

  • TCR Viral Particles

Loading...
  • Target Species:
  • TCR Clone:
  • Host Species:
  • Epitope:
  • Allele:
  • Vector Type:
CAT Product Name Target Species TCR Clone Host Species Epitope Allele Vector Type Inquiry & Datasheet
TCR-C047Z Human anti-EBNA3 T cell receptor (LC13), pCDTCR1 EBV LC13 Human FLRGRAYGL HLA-B*0801 Lentiviral   Add to Cart   Datasheet
TCR-C048Z Human anti-EBNA3 T cell receptor (CF34), pCDTCR1 EBV CF34 Human FLRGRAYGL HLA-B8 Lentiviral   Add to Cart   Datasheet
TCR-C049Z Human anti-EBNA3 T cell receptor (RL42), pCDTCR1 EBV RL42 Human FLRGRAYGL HLA-B8 Lentiviral   Add to Cart   Datasheet
TCR-C050Z Human anti-EBNA3 T cell receptor (JL12), pCDTCR1 EBV  JL12 Human FLRGRAYGL HLA-B8 Lentiviral   Add to Cart   Datasheet
Unable to find the desired product? Explore the Filter Options at the top of the list.
Key Updates
Newsletter NEWSLETTER

The latest newsletter to introduce the latest breaking information, our site updates, field and other scientific news, important events, and insights from industry leaders

LEARN MORE NEWSLETTER
New Solution NEW SOLUTION

CellRapeutics™ In Vivo Cell Engineering: One-stop in vivo T/B/NK cell and macrophage engineering services covering vectors construction to function verification.

LEARN MORE SOLUTION
NOVEL SOLUTION NOVEL TECHNOLOGY

Silence™ CAR-T Cell: A novel platform to enhance CAR-T cell immunotherapy by combining RNAi technology to suppress genes that may impede CAR functionality.

LEARN MORE NOVEL TECHNOLOGY
NEW TECHNOLOGY NEW SOLUTION

Canine CAR-T Therapy Development: From early target discovery, CAR design and construction, cell culture, and transfection, to in vitro and in vivo function validation.

LEARN MORE SOLUTION
Receive our latest news and insights.